The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
Open accessAbstract
Although metformin is widely used for the treatment of non-insulin-dependent diabetes, its mode of action remains unclear. Here we provide evidence that its primary site of action is through a direct inhibition of complex 1 of the respiratory chain. Metformin (50 μM) inhibited mitochondrial oxidation of glutamate+malate in hepatoma cells by 13 and 30% after 24 and 60 h exposure respectively, but succinate oxidation was unaffected. Metformin also caused time-dependent inhibition of complex 1 in isolated mitochondria, whereas in sub-mitochondrial particles inhibition was immediate but required very high metformin concentrations (K0.5, 79 mM). These data are compatible with the slow membrane-potential-driven accumulation of the positively charged drug within the mitochondrial matrix leading to inhibition of complex 1. Metformin inhibition of gluconeogenesis from L-lactate in isolated rat hepatocytes was also time- and concentration-dependent, and accompanied by changes in metabolite levels similar to those induced by other inhibitors of gluconeogenesis acting on complex 1. Freeze-clamped livers from metformin-treated rats exhibited similar changes in metabolite concentrations. We conclude that the drug's pharmacological effects are mediated, at least in part, through a time-dependent, self-limiting inhibition of the respiratory chain that restrains hepatic gluconeogenesis while increasing glucose utilization in peripheral tissues. Lactic acidosis, an occasional side effect, can also be explained in this way.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metformin may cause lactic acidosis through impairment of oxidative phosphorylation.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [464]
In the citing paper
“it has been shown to accumulate in mitochondria due to the membrane potential across the mitochondrial inner membrane”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Owen et al. 2000
In the citing paper
“However, metformin, one of the commonly prescribed drugs for treating type II diabetes, is safe despite acting as a mitochondrial complex I inhibitor that impairs respiration (Bridges et al., 2014; El-Mir et al., 2000; Owen et al., 2000; Wheaton et al., 2014).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Owen et al., 2000
In the citing paper
“This inhibition would in turn decrease the ATP/AMP ratio activating AMPK (127–129).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“As pointed out by Fontaine, a problem associated with accepting the argument that the therapeutic effects of metformin result from inhibition of complex 1, as depicted in Figure 1, are the high concentrations used in the cell culture studies described by El Mir et al. and Owen et al. (127, 128, 133).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“Given the evidence that metformin acts through the mitochondrial electron transport chain (ETC) by inhibiting complex I(46, 210–212) (Figure 8)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [210]
Citations
Cites
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Ebert, B. L., Firth, J. D., & Ratcliffe, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29083 · Cited by 569
Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse
Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418
Hundal, H. S., Ramlal, T., Reyes, R., Leiter, L. A., & Klip, A. (1992) · Endocrinology · doi:10.1210/endo.131.3.1505458 · Cited by 243
Perriello, G., Misericordia, P., Volpi, E., Santucci, A., Santucci, C., Ferrannini, E., Ventura, M. M., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1994) · Diabetes · doi:10.2337/diab.43.7.920 · Cited by 227
Argaud, D., Roth, H., Wiernsperger, N. F., & Leverve, X. M. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17886.x · Cited by 151
Biguanide-associated lactic acidosis. Case report and review of the literature
Gan, S. C. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.11.2333 · Cited by 129
Halestrap, A. P. (1987) · Biochemical Journal · doi:10.1042/bj2440159 · Cited by 120
Self-citationFischer, Y., Thomas, J., Rosen, P., & Kammermeier, H. (1995) · Endocrinology · doi:10.1210/endo.136.2.7835271 · Cited by 114
Cited by
Sorted by citations
Items 901–1,000 of 1,008
Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion
Wang, H., Sharma, L., Lu, J. L., Finch, P., Fletcher, S., & Prochownik, E. V. (2015) · Oncotarget · doi:10.18632/oncotarget.4327 · Cited by 41
Vélez, J., Pan, R. A., Lee, J. T. C., Enciso, L. J., Suarez, M., Duque, J. E., Jaramillo, D., López, C., Morales, L., Bornmann, W. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9843 · Cited by 41
AMPK as a Pro-longevity Target
Burkewitz, K., Weir, H. J. M., & Mair, W. B. (2016) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-319-43589-3_10 · Cited by 42
Targeting AMPK: From Ancient Drugs to New Small-Molecule Activators
Guigas, B., & Viollet, B. (2016) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-319-43589-3_13 · Cited by 44
Petrachi, T., Romagnani, A., Albini, A., Longo, C., Argenziano, G., Grisendi, G., Dominici, M., Ciarrocchi, A., & Dallaglio, K. (2016) · Oncotarget · doi:10.18632/oncotarget.14321 · Cited by 41
The citrus fruit flavonoid naringenin suppresses hepatic glucose production from Fao hepatoma cells
Purushotham, A., Tian, M., & Belury, M. A. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700514 · Cited by 43
Off‐target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
Lagunas‐Rangel, F. A., Liepinsh, E., Fredriksson, R., Alsehli, A. M., Williams, M. J., Dambrova, M., Jönsson, J., & Schiöth, H. B. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17309 · Cited by 42
Zhao, T., Yang, Q., Feuerbacher, J. F., Yu, B., Brinkmann, C. K., Cheng, S., Bloch, W., & Schumann, M. (2024) · British Journal of Sports Medicine · doi:10.1136/bjsports-2024-108127 · Cited by 41
Moon, D. O. (2024) · Applied Sciences · doi:10.3390/app14198607 · Cited by 40
Increased skeletal muscle glucose uptake by rosemary extract through AMPK activation
Naimi, M., Tsakiridis, T. K., Stamatatos, T. C., Alexandropoulos, D. I., & Tsiani, E. (2014) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2014-0430 · Cited by 40
Hong, J.-M., Kim, J. H., Kang, J. S., Lee, W. J., & Hwang, Y. (2016) · Anatomy & Cell Biology · doi:10.5115/acb.2016.49.2.88 · Cited by 40
Metformin as a new anti-cancer drug in adrenocortical carcinoma
Poli, G., Cantini, G., Armignacco, R., Fucci, R., Santi, R., Canu, L., Nesi, G., Mannelli, M., & Luconi, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10421 · Cited by 40
Yi, Y., Chen, D., Ao, J., Sun, S., Wu, M. C., Li, X., Bergholz, J. S., Zhang, Y., & Xiao, Z. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.769141 · Cited by 40
Li, S.-M. H., Liu, S., Chang, Y., Ho, C., & Huang, S. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0478-5 · Cited by 40
Metabolomics profiling of metformin-mediated metabolic reprogramming bypassing AMPKα
Yan, M., Qi, H., Xia, T., Zhao, X., Wang, W., Wang, Z., Lu, C., Ning, Z., Chen, H., Li, T., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.11.010 · Cited by 40
Biphasic effect of metformin on human cardiac energetics
Emelyanova, L. V., Bai, X., Yan, Y., Bosnjak, Z. J., Kress, D. C., Warner, C., Kroboth, S., Rudic, T., Kaushik, S., Stoeckl, E. M., et al. (2020) · Translational research · doi:10.1016/j.trsl.2020.10.002 · Cited by 41
Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC
Cheng, F., Chen, C., Tsai, W., Wang, B., Yu, M.-C., Hsia, T., Wei, Y.-L., Hsiao, Y.-C., Hu, D.-W., Ho, C.-Y., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01597-1 · Cited by 41
Leisegang, K., Almaghrawi, W., & Henkel, R. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111085 · Cited by 40
The &Bgr;-Cell in Type 2 Diabetes and in Obesity
Rutter, G. A., & Parton, L. E. (2008) · KARGER eBooks · doi:10.1159/000115360 · Cited by 41
Fujita, Y., Hosokawa, M., Fujimoto, S., Mukai, E., Abudukadier, A., Obara, A., Ogura, M., Nakamura, Y., Toyoda, K., Nagashima, K., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1729-5 · Cited by 40
AMP-activated protein kinase and hypoxic pulmonary vasoconstriction
Robertson, T. P., Mustard, K. J. W., Lewis, T. H. J., Clark, J. H., Wyatt, C. N., Blanco, E. A., Peers, C., Hardie, D. G., & Evans, A. M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.035 · Cited by 40
Garait, B., Couturier, K., Servais, S., Letexier, D., Perrin, D., Batandier, C., Rouanet, J., Sibille, B., Rey, B., Leverve, X. M., et al. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.06.026 · Cited by 42
Taming expectations of metformin as a treatment to extend healthspan
Konopka, A. R., & Miller, B. F. (2019) · GeroScience · doi:10.1007/s11357-019-00057-3 · Cited by 42
Tang, C., Xu, J. P., Ye, H.-Y., & Wang, X. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10013 · Cited by 39
Zhao, X., Zhang, X., Pei, J., Liu, Y., Niu, W., & Sun, H. (2023) · Diabetologia · doi:10.1007/s00125-023-05985-6 · Cited by 40
The direct targets of metformin in diabetes and beyond
Yao, L., Wang, L., Zhang, R., Soukas, A. A., & Wu, L. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.07.017 · Cited by 40
Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer
Litzenburger, B. C., & Brown, P. H. (2014) · Current Breast Cancer Reports · doi:10.1007/s12609-014-0144-1 · Cited by 41
Metformin: An Inhibitor of mTORC1 Signaling
Melnik, B. C., & Schmitz, G. (2014) · Cited by 39
Hung, C., Chan, S., Chu, P., Lin, H.-C., & Tsai, K. (2016) · Oncotarget · doi:10.18632/oncotarget.7387 · Cited by 41
Ramos-Peñafiel, C. O., Olarte-Carrillo, I., Maldonado, R. C., Rozen‐Fuller, E., Kassack-Ipiña, J. J., Meléndez, G., Collazo-Jaloma, J., & Martínez‐Tovar, A. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1620-6 · Cited by 40
Targeting Mitochondrial Network Architecture in Down Syndrome and Aging
Mollo, N., Cicatiello, R., Aurilia, M., Scognamiglio, R., Genesio, R., Charalambous, M., Paladino, S., Conti, A. M. F., Nitsch, L., & Izzo, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093134 · Cited by 41
PGC-1α-Targeted Therapeutic Approaches to Enhance Muscle Recovery in Aging
Petrocelli, J. J., & Drummond, M. J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17228650 · Cited by 39
Ajoolabady, A., Bi, Y., McClements, D. J., Lip, G. Y. H., Richardson, D. R., Reiter, R. J., Klionsky, D. J., & Ren, J. T. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106072 · Cited by 39
Metformin delays satellite cell activation and maintains quiescence
Pavlidou, T., Marinkovic, M., Rosina, M., Fuoco, C., Vumbaca, S., Gargioli, C., Castagnoli, L., & Cesareni, G. (2019) · Stem Cells International · doi:10.1155/2019/5980465 · Cited by 38
Metformin and the Liver: Unlocking the Full Therapeutic Potential
Perazza, F., Leoni, L., Colosimo, S., Musio, A., Bocedi, G., D’Avino, M., Agnelli, G., Nicastri, A., Rossetti, C., Sacilotto, F., et al. (2024) · Metabolites · doi:10.3390/metabo14040186 · Cited by 39
Ko, M., Kim, J., Lazim, R., Lee, J. Y., Kim, J. Y., Gosu, V., Lee, Y., Choi, S., & Kwon, H. J. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01357-1 · Cited by 40
Metformin trims fats to restore insulin sensitivity
Shaw, R. J. (2013) · Nature Medicine · doi:10.1038/nm.3414 · Cited by 38
Khallaghi, B., Safarian, F., Nasoohi, S., Ahmadiani, A., & Dargahi, L. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.024 · Cited by 38
Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans
Rotroff, D. M., Oki, N. O., Liang, X., Yee, S. W., STOCKER, S. L., Corum, D. G., Balik-Meisner, M. R., Fiehn, O., Motsinger‐Reif, A. A., Giacomini, K. M., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00135 · Cited by 38
Moral‐Sanz, J., Mahmoud, A. D., Ross, F. A., Eldstrom, J., Fedida, D., Hardie, D. G., & Evans, A. M. (2016) · The Journal of Physiology · doi:10.1113/jp272032 · Cited by 40
The critical issue linking lipids and inflammation: Clinical utility of stopping oxidative stress
Bale, B. F., Doneen, A. L., Leimgruber, P. P., & Vigerust, D. J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1042729 · Cited by 39
Mukhtar, M. H., Payne, V. A., Arden, C., Harbottle, A., Khan, S. A., Lange, A. J., & Agius, L. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00593.2007 · Cited by 39
Metformin prevents cerebellar granule neurons against glutamate-induced neurotoxicity
Zhou, C., Sun, R., Zhuang, S., Sun, C., Jiang, Y., Cui, Y., Li, S., Xiao, Y., Du, Y., Gu, H., et al. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.02.009 · Cited by 38
Bulterijs, S. (2011) · Rejuvenation Research · doi:10.1089/rej.2011.1153 · Cited by 37
Mailloux, R. J., Young, A., Chalker, J., Gardiner, D., O’Brien, M., Slade, L., & Brosnan, J. T. (2016) · FEBS Letters · doi:10.1002/1873-3468.12461 · Cited by 37
Effect of metformin on exercise capacity: A meta-analysis
Das, S., Behera, S. K., Srinivasan, A., Xavier, A. S., Selvarajan, S., Kamalanathan, S., Sahoo, J. P., & Nair, N. S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.08.022 · Cited by 41
Smith, H. W., Hirukawa, A., Sanguin‐Gendreau, V., Nandi, I., Dufour, C. R., Zuo, D., Tandoc, K. V., Leibovitch, M., Singh, S., Rennhack, J. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10681-4 · Cited by 37
A Fbxo48 inhibitor prevents pAMPKα degradation and ameliorates insulin resistance
Liu, Y., Jurczak, M. J., Lear, T., Lin, B., Larsen, M. B., Kennerdell, J. R., Chen, Y., Huckestein, B. R., Nguyen, M. K., Tuncer, F., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-020-00723-0 · Cited by 37
Recent Pharmacological Options in Type 2 Diabetes and Synergic Mechanism in Cardiovascular Disease
Andreadi, A., Muscoli, S., Tajmir, R., Meloni, M., Muscoli, C., Ilari, S., Mollace, V., Della‐Morte, D., Bellia, A., Daniele, N. D., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021646 · Cited by 36
Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes
Otto, M., Breinholt, J., & Westergaard, N. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00263.x · Cited by 39
Recent advances in molecular mechanisms of acute kidney injury in patients with diabetes mellitus
Infante, B., Conserva, F., Pontrelli, P., Leo, S., Stasi, A., Fiorentino, M., Troise, D. E., Strologo, A. D., Alfieri, C., Gesualdo, L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.903970 · Cited by 37
Targeting AMPK in the treatment of malignancies
Vakana, E., Altman, J. K., & Platanias, L. C. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23369 · Cited by 37
Joshi, S., Liu, M., & Turner, N. A. (2015) · BioMed Research International · doi:10.1155/2015/390863 · Cited by 36
Samuels, A. L., Heng, J. Y., Beesley, A. H., & Kees, U. R. (2014) · British Journal of Haematology · doi:10.1111/bjh.12727 · Cited by 36
The regulation effect of AMPK in immune related diseases
Wang, J., Li, Z., Gao, L., Qi, Y., Zhu, H., & Qin, X. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9169-6 · Cited by 37
Weiss, R., Fernández, E., Liu, Y., Strong, R., & Salmon, A. B. (2018) · Aging · doi:10.18632/aging.101401 · Cited by 39
Meng, X., Zhang, X., Lei, Y., Cao, D., & Wang, Z. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02476g · Cited by 36
Chen, A., Kristiansen, C. K., Hong, Y., Kianian, A., Fang, E. F., Sullivan, G. J., Wang, J., Li, X., Bindoff, L. A., & Liang, K. X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.737304 · Cited by 36
Donovan, L., & Severin, N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1498 · Cited by 36
Arulmozhi, D. K., Kurian, R., Bodhankar, S. L., & Veeranjaneyulu, A. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.9.0008 · Cited by 36
Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk
Lauretta, R., Lanzolla, G., Vici, P., Mariani, L., Moretti, C., & Appetecchia, M. (2016) · International Journal of Endocrinology · doi:10.1155/2016/8671762 · Cited by 36
Toxic medications in Leber's hereditary optic neuropathy
Kogachi, K., Ter‐Zakarian, A., Asanad, S., Sadun, A. A., & Karanjia, R. (2018) · Mitochondrion · doi:10.1016/j.mito.2018.07.007 · Cited by 36
Impact of diabetes on promoting the growth of breast cancer
Chou, P., Choi, H. H., Huang, Y., Fuentes‐Mattei, E., Velazquez‐Torres, G., Zhang, F., Phan, L., Lee, J., Shi, Y., Bankson, J. A., et al. (2021) · Cancer Communications · doi:10.1002/cac2.12147 · Cited by 35
Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor Behind the Scene
Anwar, M. A., Kheir, W. A., Eid, S., Fares, J., Liu, X., Eid, A. H., & Eid, A. A. (2014) · Journal of Cancer · doi:10.7150/jca.9726 · Cited by 35
Khaleghi-Mehr, M., Delshad, A.-A., Shafie-Damavandi, S., & Roghani, M. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01170-1 · Cited by 37
Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications
Tashkandi, A. J. A., Gorman, A., Mathers, E. M., Carney, G., Yacoub, A., Setyaningsih, W. A. W., Kuburas, R., & Margariti, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073016 · Cited by 35
Maayah, Z. H., Ghebeh, H., Alhaider, A. A., El‐Kadi, A. O. S., Soshilov, A. A., Denison, M. S., Ansari, M. A., & Korashy, H. M. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.02.007 · Cited by 35
Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges
Yung, M. M. H., Ngan, H., & Chan, D. W. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv128 · Cited by 35
Metformin reveals a mitochondrial copper addiction of mesenchymal cancer cells
Müller, S., Versini, A., Sindikubwabo, F., Belthier, G., Niyomchon, S., Pannequin, J., Grimaud, L., Cañeque, T., & Rodriguez, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206764 · Cited by 35
MALDI-MSI analysis of cancer drugs: Significance, advances, and applications
He, Q., Sun, C., Liu, J., & Pan, Y. (2021) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2021.116183 · Cited by 35
Shizu, R., Shindo, S., Yoshida, T., & Numazawa, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041291 · Cited by 35
Zakikhani, M., Bazile, M., Hashemi, S., Javeshghani, S., Avizonis, D. Z., St‐Pierre, J., & Pollak, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049513 · Cited by 36
AMP-activated protein kinase and energy balance in breast cancer.
Zhao, H., Orhan, Y. C., Zha, X., Esencan, E., Chatterton, R. T., & Bulun, S. E. (2017) · Europe PMC (PubMed Central) · Cited by 35
de Lima, E. A., de Sousa, L. G. O., Teixeira, A. A. D. S., Marshall, A. G., Zanchi, N. E., & Neto, J. C. R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26880 · Cited by 34
Eckstein, M. L., Williams, D. M., O'Neil, L., Hayes, J., Stephens, J. W., & Bracken, R. M. (2018) · Diabetic Medicine · doi:10.1111/dme.13865 · Cited by 34
Gao, Y., Gu, C., Wang, K., Wang, H., Ruan, K., Xu, Z., & Feng, Y. (2017) · Phytotherapy Research · doi:10.1002/ptr.6003 · Cited by 34
Yousuf, Y., Datu, A., Barnes, B., Amini‐Nik, S., & Jeschke, M. G. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1480-x · Cited by 34
Moonira, T., Chachra, S. S., Ford, B. E., Marín, S., Alshawi, A., Adam-Primus, N. S., Arden, C., Al‐Oanzi, Z. H., Foretz, M., Viollet, B., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012533 · Cited by 35
Toxicity of Metformin and Hypoglycemic Therapies
Akhter, M. S., & Uppal, P. (2020) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.08.004 · Cited by 36
AMPK allostery: A therapeutic target for the management/treatment of diabetic nephropathy
Ayinde, K. S., Olaoba, O. T., Boyenle, I. D., Du, L., Lü, Q., Yin, X., & Adelusi, T. I. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118455 · Cited by 34
Han, T.-H., Park, M. K., Nakamura, H., & Ban, H. S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112500 · Cited by 35
Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro
UEHARA, T., Mitsuhashi, A., Tsuruoka, N., & Shozu, M. (2014) · Oncology Reports · doi:10.3892/or.2014.3611 · Cited by 36
Hohnholt, M. C., Blumrich, E., Waagepetersen, H. S., & Dringen, R. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24050 · Cited by 34
MATE2 Expression Is Associated With Cancer Cell Response to Metformin
Chowdhury, S., Yung, E., Pintilie, M., Muaddi, H., Chaib, S., Yeung, M., Fusciello, M., Sykes, J., Pitcher, B., Hagenkort, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165214 · Cited by 33
Metformina e AMPK: um antigo fármaco e uma nova enzima no contexto da síndrome metabólica
Santomauro Jún, A. C., Ugolini, M. R., Santomauro, A. T., & Souto, R. P. D. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000100017 · Cited by 33
Isop, L. M., Neculau, A. E., Necula, R. D., Kakucs, C., Moga, M., & Dima, L. (2023) · Pharmaceuticals · doi:10.3390/ph16121714 · Cited by 36
Metformin: From diabetes to cancer to prolongation of life
Sirtori, C. R., Castiglione, S., & Pavanello, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107367 · Cited by 38
Mitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy
Ahn, M., Ali, A., & Seo, J. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1453886 · Cited by 33
Martineau, L. C. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.11.012 · Cited by 33
Update on the Protective Molecular Pathways Improving Pancreatic Beta-Cell Dysfunction
Puddu, A., Sanguineti, R., Mach, F., Dallegri, F., Viviani, G. L., & Montecucco, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/750540 · Cited by 33
Metformin: a new option in cancer treatment
Belda-Iniesta, C., Pernía, O., & Simó, R. (2011) · Clinical & Translational Oncology · doi:10.1007/s12094-011-0669-y · Cited by 33
Fasting promotes functional changes in liver mitochondria
Menezes‐Filho, S. L., Amigo, I., Luévano‐Martínez, L. A., & Kowaltowski, A. J. (2018) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2018.11.017 · Cited by 33
Mitochondrial targets of metformin—Are they physiologically relevant?
Pecinová, A., Brázdová, A., Drahota, Z., Houštěk, J., & Mráček, T. (2019) · BioFactors · doi:10.1002/biof.1548 · Cited by 33
Kang, H. S., Lee, J. H., Oh, K., Lee, E., Han, B., Park, K.-Y., Suh, J. M., Min, J., Chi, S., Lee, S. C., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154173 · Cited by 33
Enhanced liver but not muscle OXPHOS in diabetes and reduced glucose output by complex I inhibition
Alimujiang, M., Xue-ying, Y., Yu, M., Hou, W., Yan, Z., Yang, Y., Bao, Y., & Yin, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15238 · Cited by 33
Metformin Biodistribution: A Key to Mechanisms of Action?
Sundelin, E. I. O., Jensen, J., Jakobsen, S., Gormsen, L. C., & Jessen, N. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa332 · Cited by 34
Glucose Metabolism in Burns—What Happens?
Bădoiu, S. C., Miricescu, D., Stănescu-Spînu, I.-I., Totan, A., Badoiu, S. E., Costagliola, M., & Greabu, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105159 · Cited by 35
Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer
Wedam, R., Greer, Y. E., Wisniewski, D. J., Weltz, S., Kundu, M., Voeller, D. M., & Lipkowitz, S. (2023) · Cancers · doi:10.3390/cancers15071936 · Cited by 36
Acute renal metabolic effect of metformin assessed with hyperpolarised MRI in rats
Qi, H., Nielsen, P. M., Schroeder, M., Bertelsen, L. B., Palm, F., & Laustsen, C. (2017) · Diabetologia · doi:10.1007/s00125-017-4445-6 · Cited by 33
From old to new — Repurposing drugs to target mitochondrial energy metabolism in cancer
Aminzadeh-Gohari, S., Weber, D. D., Vidali, S., Catalano, L., Kofler, B., & Feichtinger, R. G. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.025 · Cited by 34
Metadata
- Authors
- OWEN, M. R., DORAN, E., & HALESTRAP, A. P.
- Affiliations
- University of Bristol (GB)
- ORCID
- HALESTRAP, Andrew P.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2000-06-07
- Volume
- 348
- Issue
- 3
- Pages
- 607-614
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1221104
- OpenAlex
- W1995069275
- Cited by
- 2,157
- References
- 35
- Citations by year
- 2026: 64 · 2025: 78 · 2024: 92 · 2023: 125 · 2022: 127 · 2021: 157 · 2020: 163 · 2019: 144 · 2018: 142 · 2017: 144 · 2016: 139 · 2015: 126 · 2014: 135 · 2013: 112 · 2012: 75
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UWE Research Repository (UWE Bristol) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, mitochondrial complex I inhibition, mitochondrial respiratory chain, type 2 diabetes, gluconeogenesis, hepatocytes, mitochondrial membrane potential, lactic acidosis, glucose utilization, mechanism of action
- MeSH terms
- Animals, Electron Transport, Gluconeogenesis, Hypoglycemic Agents, Liver, Male, Metformin, Mitochondria, NADH, NADPH Oxidoreductases, Submitochondrial Particles, Tumor Cells, Cultured, Signal Transduction, Rats, Wistar, Electron Transport Complex I, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
